Related Experiment Video

Updated: May 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Lung cancer: locally advanced NCSLC in the elderly: which treatment?

Cesare Gridelli

    Nature Reviews. Clinical Oncology
    |July 11, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 20, 2026

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Correction: Maione et al. Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option? Curr. Oncol. 2026, 33, 54.

    Current oncology (Toronto, Ont.)·2026

    Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

    Lung cancer (Amsterdam, Netherlands)·2026

    Lorlatinib and Amivantamab: A Paradigm Shift in EGFR and ALK Positive NSCLC, with More Effective but More Toxic Treatments Requiring a Well-Structured Shared Decision Making.

    Oncology research·2026

    Critique of phase II agents for non-small cell lung cancer: what is our clinical need and which agents have potential?

    Expert opinion on investigational drugs·2026

    Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.

    Cancer treatment and research communications·2026

    Amivantamab Plus Lazertinib and Platin-Based Chemotherapy Plus Osimertinib in EGFR-Mutant NSCLC: How to Choose Among Them and When Is Monotherapy with Osimertinib Still the Best Option?

    Current oncology (Toronto, Ont.)·2026

    Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology.

    Nature reviews. Clinical oncology·2026

    Exploring the landscape of targetable alterations in patients with glioblastoma.

    Nature reviews. Clinical oncology·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    Targeted Delivery of Carvacrol via TPGS-Tf-Polydopamine Nanoconjugate Scaffold on TNBC Tumor Xenograft for Understanding In Vivo Tumor Dynamics and 3D Cancer Spheroid Model, Mimicking a Tumor Environment.

    Molecular pharmaceutics·2026

    Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

    Molecular pharmaceutics·2026

    Low-Density Lipoprotein-Mimetic Nanoparticles Codelivering Self-Activated Cabazitaxel Prodrug and Verteporfin for Tumor Chemophotodynamic Therapy and Immune Activation.

    Molecular pharmaceutics·2026

    Correlation Between the Extent of Lateral Neck Lymph Node Dissection and Postoperative Parathyroid Function in Papillary Thyroid Carcinoma.

    Journal of investigative surgery : the official journal of the Academy of Surgical Research·2026

    The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

    Radiology and oncology·2026

    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience.

    Radiology and oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us